Timmaron Group of Minnesota invests in Open Therapeutics, LLC
Open Therapeutics, LLC owns Therapoid. Therapoid is a scientific collaboration platform that crowdsources scientists, particularly the underserved in Africa, Asia, and Latin America, around freely provided Intellectual property. Therapoid not only provides IP, but grants, free lab equipment, manuscript development tools, and preprint server for achieving open access publications and pushing technology development forward. For more information about Open Therapeutics visit (https://OpenTherapeutics.org) or visit (https://Therapoid.net) to register.
Open Therapeutics CEO, Jerome Hamilton says their mission is to help make healthcare affordable and accessible globally. Hamilton says “We are honored to have the Timmaron Group as a member of our investment community, assisting us in making the world a better place.
Barb Stinett CEO & Founder of the Timmaron group says “We are delighted to be a part of the larger Open Therapeutics team. We are impressed with the Open Therapeutics business model and see this as a double bottom line impact which can increase return on our investment while making a positive difference in the scientific research and healthcare space. We have also been very impressed with the Open Therapeutics leadership team and are looking forward to helping Jerome and his team get further acclimated to the Twin Cities business community. For more information about Timmaron Group visit (https://Timmarongroup.com).